Bell John K 4
4 · DelMar Pharmaceuticals, Inc. · Filed Jul 3, 2018
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Other
Common Stock
2018-06-29$3.20/sh+282$902→ 95,865 total(indirect: Held by Onbelay Capital Inc.)
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.